Lv32
292 积分 2021-10-28 加入
P0126 GS-8670: An Intestinally Targeted Farnesoid X Receptor Agonist Restoring Barrier Integrity and Demonstrating Robust Efficacy in Colitis Models
15天前
已关闭
P0126 GS-8670: An Intestinally Targeted Farnesoid X Receptor Agonist Restoring Barrier Integrity and Demonstrating Robust Efficacy in Colitis Models
15天前
已完结
Efficacy and safety of a novel low-dose triple single-pill combination of telmisartan, amlodipine and indapamide, compared with dual combinations for treatment of hypertension: a randomised, double-blind, active-controlled, international clinical trial
22天前
已完结
Widaplik: A Fixed-Dose Triple Combination for Initial Hypertension Therapy
22天前
已关闭
Epidemiology of cardiovascular disease in China: current features and implications
27天前
已完结
P0126 GS-8670: An Intestinally Targeted Farnesoid X Receptor Agonist Restoring Barrier Integrity and Demonstrating Robust Efficacy in Colitis Models
1个月前
已关闭
Disruption of branched-chain amino acid homeostasis promotes the progression of DKD via enhancing inflammation and fibrosis-associated epithelial-mesenchymal transition
2个月前
已完结
Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial
2个月前
已完结
Statins and Inflammation
3个月前
已完结
Cold receptor TRPM8 as a target for migraine-associated pain and affective comorbidities
3个月前
已关闭
皖公网安备34019202002308
